Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Superstring Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$106M
Portfolio companies 8
Rounds per year 3.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Biopharma
  • Pharmaceutical
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Superstring Capital:
Typical Co-investors
Superstring Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Superstring Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3D Systems Rock Hill, South Carolina, United States
Caribou Asset Management -
Cronus Bike China, Guangdong Province, Panyu District
Gamma3 Brazil, Curitiba, Paraná
Ibtikar Fund Area A, Palestinian Territory, West Bank
Incapital Chicago, Illinois, United States
Jinfu Ziben Beijing, Beijing, China
Katana Fund -
Marlin Equity Partners California, Hermosa Beach, United States
Montlake Capital Seattle, United States, Washington
Oman Investment Fund Masqat, Muscat, Oman
Power Generations, Inc. Florida, Pompano Beach, United States
Redfig -
Shoei Chemical -
Transmedia Ventures California, San Francisco, United States
Tricle Japan, Tokyo
Verbena Communications -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sironax

Biotechnology
$200M02 Aug 2022 Dongcheng District, Beijing, China

Shoreline Biosciences

Biotechnology
Life Science
Medical
$140M02 Nov 2021 San Diego, California, United States

ReCode Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Wellness
$80M21 Oct 2021 Dallas, Texas, United States

dMed

Biopharma
Medical
Pharmaceutical
$50M10 Jul 2021 Shanghai, China

Clinipace

Biotechnology
Clinical Trials
Medical
$50M08 Jul 2021 North Carolina, United States

Biopharma
Biotechnology
Health Care
Pharmaceutical
$105M13 May 2021 Shanghai, China

AffaMed Therapeutics

Biotechnology
$170M30 Mar 2021 New York, United States

Nurotron Biotechnology

Biotechnology
Electronics
Enterprise
$24M09 Oct 2020 Shangcheng District, Zhejiang, China
News
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

– ReCode Therapeutics announced the closing of an $80m Series B financing round co-led by Pfizer Ventures and EcoR1 Capital.
– The round was led by Pfizer Ventures and EcoR1 Capital.
– New investors include Sanofi Ventures, funds managed by Tekla Capital Management, Superstring Capital and NS Investment.
– Existing investors who participated included OrbiMed, Vida Ventures, MPM Capital, Colt Ventures, Hunt Technology Ventures, and Osage University Partners.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Superstring Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: